Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
Clinical trial NCT04665284 · COMPLETED
Trial details
- NCT number
- NCT04665284
- Sponsor
- Getz Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2020-09-15
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.